Acute Kidney Injury News

Mission Therapeutics has received FDA approval to initiate a phase 2 clinical trial for its drug MTX652 to treat AKI after cardiac surgery, according to a press release.

Community-acquired AKI is a common entity associated with serious adverse clinical outcomes during the 6-month period after diagnosis, according to a recently published study.

Brief dialysis may lead to better outcomes for patients with AKI on outpatient hemodialysis, according to recently published data from researchers at the University of California, San Francisco.

Patients admitted for an emergency general surgery condition had nearly 70% reduced odds of readmission if they had a primary care physician follow-up visit within 30 days of discharge, a study found.

The percentage of patients in Alberta, Canada, who received optimal care after an AKI episode was low and may signal a need to improve outcomes, according to a recently published study.

In a hearing on September 21, an FDA committee rejected an implantable device capable of delivering a GLP-1 receptor agonist for adults with type 2 diabetes.

Kidney disease progression after 5 years may be strongly associated with AKI, according to the results of a U.K.-based parallel-group cohort study.

A short course of inorganic dietary nitrate reduced contrast-induced kidney injury in high-risk patients with non-ST segment elevation ACS referred for invasive coronary angiography, researchers reported.

Use of lithium vs. valproate as a prophylactic treatment may be associated with adverse kidney outcomes, including AKI, according to recently published research.

Mitochondrial transplantation may be effective in mitigating or reversing kidney damage, according to study results from researchers at the Wake Forest University School of Medicine.